249 related articles for article (PubMed ID: 16609008)
21. Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells.
Jewett A; Cavalcanti M; Bonavida B
J Immunol; 1997 Nov; 159(10):4815-22. PubMed ID: 9366406
[TBL] [Abstract][Full Text] [Related]
22. Quantitative analysis of the effect of CD16 ligation on human NK cell proliferation.
Warren HS; Kinnear BF
J Immunol; 1999 Jan; 162(2):735-42. PubMed ID: 9916693
[TBL] [Abstract][Full Text] [Related]
23. [NK cell receptors and related ligands].
Pan B; Chen YH; Zhu LP; He W; Zhang W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):650-2. PubMed ID: 12905699
[TBL] [Abstract][Full Text] [Related]
24. IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors.
Sivori S; Cantoni C; Parolini S; Marcenaro E; Conte R; Moretta L; Moretta A
Eur J Immunol; 2003 Dec; 33(12):3439-47. PubMed ID: 14635054
[TBL] [Abstract][Full Text] [Related]
25. Potent induction of TNF-alpha during interaction of immune effectors with oral tumors as a potential mechanism for the loss of NK cell viability and function.
Romero-Reyes M; Head C; Cacalano NA; Jewett A
Apoptosis; 2007 Nov; 12(11):2063-75. PubMed ID: 17713857
[TBL] [Abstract][Full Text] [Related]
26. Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab')2 fragment of anti-CD16 antibody.
Jewett A; Teruel A; Romero M; Head C; Cacalano N
Cancer Immunol Immunother; 2008 Jul; 57(7):1053-66. PubMed ID: 18188563
[TBL] [Abstract][Full Text] [Related]
27. CD16 polymorphisms and NK activation induced by monoclonal antibody-coated target cells.
Bowles JA; Weiner GJ
J Immunol Methods; 2005 Sep; 304(1-2):88-99. PubMed ID: 16109421
[TBL] [Abstract][Full Text] [Related]
28. Interaction of human immunoglobulin G with CD16 on natural killer cells: ligand clearance, FcgammaRIIIA turnover and effects of metalloproteinases on FcgammaRIIIA-mediated binding, signal transduction and killing.
Mota G; Moldovan I; Calugaru A; Hirt M; Kozma E; Galatiuc C; Brasoveanu L; Boltz-Nitulescu G
Scand J Immunol; 2004 Mar; 59(3):278-84. PubMed ID: 15030579
[TBL] [Abstract][Full Text] [Related]
29. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen.
Pérez-Villar JJ; Melero I; Rodríguez A; Carretero M; Aramburu J; Sivori S; Orengo AM; Moretta A; López-Botet M
J Immunol; 1995 Jun; 154(11):5779-88. PubMed ID: 7751628
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of anti-GD3-ganglioside antibody-induced proliferation of human CD8+ T cells by CD16+ natural killer cells.
Claus C; Schlaak J; Dittmayer M; Meyer zum Büschenfelde K; Dippold W
Eur J Immunol; 1994 May; 24(5):1208-12. PubMed ID: 8181530
[TBL] [Abstract][Full Text] [Related]
31. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor.
Borrego F; Masilamani M; Kabat J; Sanni TB; Coligan JE
Mol Immunol; 2005 Feb; 42(4):485-8. PubMed ID: 15607803
[TBL] [Abstract][Full Text] [Related]
32. CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells.
Palmieri G; Tullio V; Zingoni A; Piccoli M; Frati L; Lopez-Botet M; Santoni A
J Immunol; 1999 Jun; 162(12):7181-8. PubMed ID: 10358164
[TBL] [Abstract][Full Text] [Related]
33. Isolation and characterization of anti-FcgammaRIII (CD16) llama single-domain antibodies that activate natural killer cells.
Behar G; Sibéril S; Groulet A; Chames P; Pugnière M; Boix C; Sautès-Fridman C; Teillaud JL; Baty D
Protein Eng Des Sel; 2008 Jan; 21(1):1-10. PubMed ID: 18073223
[TBL] [Abstract][Full Text] [Related]
34. Decreased natural killer (NK) cell function in chronic NK cell lymphocytosis associated with decreased surface expression of CD11b.
Orange JS; Chehimi J; Ghavimi D; Campbell D; Sullivan KE
Clin Immunol; 2001 Apr; 99(1):53-64. PubMed ID: 11286541
[TBL] [Abstract][Full Text] [Related]
35. Compensatory effect of TNFalpha on low natural killer activity in the elderly.
Myśliwska J; Bryl E; Trzonkowski P; Myśliwski A
Acta Biochim Pol; 2000; 47(2):301-11. PubMed ID: 11051195
[TBL] [Abstract][Full Text] [Related]
36. Beneficial effect of short-term exposure of human NK cells to IL15/IL12 and IL15/IL18 on cell apoptosis and function.
Sotiriadou NN; Perez SA; Gritzapis AD; Mahaira LG; Salagianni M; Baxevanis CN; Papamichail M
Cell Immunol; 2005 Mar; 234(1):67-75. PubMed ID: 16024007
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
Liao YH; Jee SH; Sheu BC; Huang YL; Tseng MP; Hsu SM; Tsai TF
Br J Dermatol; 2006 Aug; 155(2):318-24. PubMed ID: 16882169
[TBL] [Abstract][Full Text] [Related]
38. [Different responses of CD94/NKG2A-bright and CD94/NKG2A-dim NK cell subsets isolated from patients with multiple sclerosis to interferon-beta].
Li L; Deng YC; Zhao G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun; 23(6):533-5. PubMed ID: 17553351
[TBL] [Abstract][Full Text] [Related]
39. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway.
Zeddou M; Greimers R; de Valensart N; Nayjib B; Tasken K; Boniver J; Moutschen M; Rahmouni S
Biochem Pharmacol; 2005 Sep; 70(5):714-24. PubMed ID: 15978547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
